Bacterial Tracheitis

Back

Practice Essentials

Except in patients with a tracheostomy or endotracheal tube, bacterial tracheitis is an uncommon infectious cause of acute upper airway obstruction. It is currently more prevalent than acute epiglottitis in children who have received Haemophilus type B vaccine. Patients may present with crouplike symptoms, such as barking cough, stridor, and fever; however, patients with bacterial tracheitis do not respond to standard croup therapy (racemic epinephrine) and instead require treatment with antibiotics and may experience acute respiratory decompensation.[1, 2, 3, 22]

 

Pathophysiology

Bacterial tracheitis is a diffuse inflammatory process of the larynx, trachea, and bronchi with adherent or semiadherent mucopurulent membranes within the trachea. The major site of disease is at the cricoid cartilage level, the narrowest part of the trachea. Acute airway obstruction may develop secondary to subglottic edema and sloughing of epithelial lining or accumulation of mucopurulent membrane within the trachea. Signs and symptoms are usually intermediate between those of epiglottitis and croup.[4, 5]

Bacterial tracheitis may be more common in the pediatric patient because of the size and shape of the subglottic airway. The subglottis is the narrowest portion of the pediatric airway, assuming a funnel-shaped internal dimension. In this smaller airway, relatively little edema can significantly reduce the diameter of the pediatric airway, increasing resistance to airflow and work of breathing. With appropriate airway support and antibiotics, most patients improve within 5 days.

Although the pathogenesis of bacterial tracheitis is unclear, mucosal damage or impairment of local immune mechanisms due to a preceding viral infection, an injury to the trachea from recent intubation, or trauma may predispose the airway to invasive infection with common pyogenic organisms.

Epidemiology

Frequency

United States

Tan and Manoukian reported that 500 children were hospitalized for croup at one pediatric hospital over a 32-month period.[6] Approximately 98% had viral croup, and 2% had bacterial tracheitis. Cases usually occur in the fall or winter months, mimicking the epidemiology of viral croup.

A study that described the frequency and severity of complications in hospitalized children younger than 18 years with seasonal influenza (during 2003-2009) and 2009 pandemic influenza A(H1N1) (during 2009-2010) reported that out of 7293 children hospitalized with influenza, less than 2% had complications from tracheitis. However, along with other rare complications, tracheitis was associated with a median hospitalization duration of more than 6 days, with 48%-70% of children requiring intensive care.[7]

International

According to a recent study, bacterial tracheitis remains a rare condition, with an estimated incidence of approximately 0.1 cases per 100,000 children per year.[8]

Mortality/Morbidity

The predominant morbidity and mortality is related to the potential for acute upper airway obstruction and induced hypoxic insults. The mortality rate has been estimated at 4-20%. In the acute phase, patients generally do well if the airway is adequately managed and if antibiotic therapy is promptly initiated.

Sex

In most epidemiologic studies, male cases are preponderant. Gallagher et al reported a male-to-female predominance of 2:1.[9]

Age

Bacterial tracheitis may occur in any pediatric age group. Gallagher et al reported 161 cases of patients younger than 16 years.[9] The age range was from 3 weeks to 16 years, with a mean age of 4 years. This is in contrast to viral laryngotracheobronchitis, which occurs in patients aged 6 months to 3 years.

History

Symptoms of bacterial tracheitis may be intermediately between those of epiglottitis and croup. Presentation is either acute or subacute.

Physical

The following physical findings may be noted:

Causes

The following causes have been noted:

Laboratory Studies

Obtain bacterial culture and Gram stain of tracheal secretions and blood cultures in patients with suspected bacterial tracheitis.

Imaging Studies

Radiography of the neck may be indicated.

Procedures

Laryngotracheobronchoscopy is indicated.

Medical Care

Treatment of bacterial tracheitis consists of the following:

Surgical Care

Tracheostomy is rarely necessary unless injury or trauma to the airway has caused scarring and documented narrowing of the airway. Tracheostomy is necessary if the patient has failed extubations despite appropriate medical management or if intubation is prolonged. Pulmonary toilet is potentially better with tracheostomy.

Consultations

The following consultations may be indicated:

Oxacillin (Bactocill, Prostaphlin)

Clinical Context:  Provides empiric therapy against etiologic agents, specifically penicillinase-producing strains of Staphylococcus.

Cefotaxime (Claforan)

Clinical Context:  Provides empiric therapy, especially against H influenzae, and modest activity against anaerobes.

Vancomycin (Vancocin)

Clinical Context:  May be used in severe cases or in cases with a history of allergies instead of oxacillin for coverage of gram-positive organisms (eg, S aureus, S pyogenes).

Clindamycin (Cleocin)

Clinical Context:  Use in combination with chloramphenicol in patients who are allergic to penicillin. Clindamycin in combination with cefuroxime is an acceptable regimen for patients who are not allergic.

Class Summary

Empiric antimicrobial therapy in bacterial tracheitis must be comprehensive and should cover all likely pathogens in the context of the clinical setting.

Further Outpatient Care

Patient should complete an appropriate course (usually 10 d) of oral antibiotics.

Further Inpatient Care

Consider extubation when bacterial tracheitis appears to be resolving, especially with decreased secretions suctioned from the endotracheal tube.

Transfer

Transfer is required for patients in respiratory distress, patients in need of a pediatric intensive care unit, and patients who need a pediatric-sized bronchoscope.

Complications

The following complications have been reported:

A retrospective study by Gross et al, in which four patients who received antibiotic treatment for bacterial laryngotracheitis showed improvement in presumed iatrogenic laryngotracheal stenosis, suggested that airway bacterial growth is significantly involved in adult postintubation airway injury. The patients had a history of intubation and/or tracheostomy, with complete resolution of upper airway obstruction seen in three of the patients after laryngotracheitis treatment and significant improvement of airway status seen in the fourth.[15]

Prognosis

Once the patient is past the acute phase, complete recovery is expected.

Patient Education

Keep immunizations up-to-date.

What is bacterial tracheitis?What is the pathophysiology of bacterial tracheitis?What is the prevalence of bacterial tracheitis in the US?What is the global prevalence of bacterial tracheitis?What is the morbidity of bacterial tracheitis?What is the sexual predilection of bacterial tracheitis?Which age groups have the highest prevalence of bacterial tracheitis?Which clinical history findings are characteristic of bacterial tracheitis?Which physical findings are characteristic of bacterial tracheitis?What causes bacterial tracheitis?What are the differential diagnoses for Bacterial Tracheitis?What is the role of lab testing in the workup of bacterial tracheitis?What is the role of radiography in the workup of bacterial tracheitis?What is the role of laryngotracheobronchoscopy in the workup of bacterial tracheitis?How is bacterial tracheitis treated?What is the role of surgery in the treatment of bacterial tracheitis?Which specialist consultations are beneficial to patients with bacterial tracheitis?What is the duration of oral antibiotics for the treatment of bacterial tracheitis?What are the indications for extubation in bacterial tracheitis?When should patient transfer be considered for the treatment of bacterial tracheitis?What are the possible complications of bacterial tracheitis?What is the prognosis of bacterial tracheitis?What is included in patient education about bacterial tracheitis?Which medications in the drug class Antibiotic agents are used in the treatment of Bacterial Tracheitis?

Author

Sujatha Rajan, MD, Assistant Professor of Pediatrics, Albert Einstein School of Medicine; Consulting Staff, Department of Pediatrics, Division of Pediatric Infectious Diseases, Schneider Children's Hospital, North Shore-Long Island Jewish Health System

Disclosure: Nothing to disclose.

Coauthor(s)

Kathryn Clark Emery, MD, Associate Professor, Department of Pediatrics, University of Colorado Health Sciences Center; Consulting Staff, Department of Emergency Medicine, Children's Hospital of Denver

Disclosure: Nothing to disclose.

Sunil K Sood, MBBS, , MD, Professor of Clinical Pediatrics, Department of Pediatrics, Albert Einstein College of Medicine; Chief, Pediatric Infectious Diseases, Firm Director, Pediatric Unit, Schneider Children's Hospital at North Shore, North Shore University Hospital

Disclosure: Nothing to disclose.

Specialty Editors

Mary L Windle, PharmD, Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Joseph Domachowske, MD, Professor of Pediatrics, Microbiology and Immunology, Department of Pediatrics, Division of Infectious Diseases, State University of New York Upstate Medical University

Disclosure: Received research grant from: Pfizer;GlaxoSmithKline;AstraZeneca;Merck;American Academy of Pediatrics, Novavax, Regeneron, Diassess, Actelion<br/>Received income in an amount equal to or greater than $250 from: Sanofi Pasteur.

Chief Editor

Russell W Steele, MD, Clinical Professor, Tulane University School of Medicine; Staff Physician, Ochsner Clinic Foundation

Disclosure: Nothing to disclose.

References

  1. Huang YL, Peng CC, Chiu NC, et al. Bacterial tracheitis in pediatrics: 12 year experience at a medical center in Taiwan. Pediatr Int. 2009 Feb. 51(1):110-3. [View Abstract]
  2. Johnson D. Croup. Clin Evid (Online). 2009 Mar 10. 2009:[View Abstract]
  3. Holmes A. Croup: What It Is and How to Treat It. US Pharm. 2013. 38(7):47-50.
  4. Miranda AD, Valdez TA, Pereira KD. Bacterial tracheitis: a varied entity. Pediatr Emerg Care. 2011 Oct. 27(10):950-3. [View Abstract]
  5. Zoorob R, Sidani M, Murray J. Croup: an overview. Am Fam Physician. 2011 May 1. 83(9):1067-73. [View Abstract]
  6. Tan AK, Manoukian JJ. Hospitalized croup (bacterial and viral): the role of rigid endoscopy. J Otolaryngol. 1992 Feb. 21(1):48-53. [View Abstract]
  7. Dawood FS, Chaves SS, Pérez A, Reingold A, Meek J, Farley MM, et al. Complications and associated bacterial coinfections among children hospitalized with seasonal or pandemic influenza, United States, 2003-2010. J Infect Dis. 2014 Mar 1. 209(5):686-94. [View Abstract]
  8. Tebruegge M, Pantazidou A, Thorburn K, et al. Bacterial tracheitis: a multi-centre perspective. Scand J Infect Dis. 2009 Apr 28. 1-10. [View Abstract]
  9. Gallagher PG, Myer CM 3d. An approach to the diagnosis and treatment of membranous laryngotracheobronchitis in infants and children. Pediatr Emerg Care. 1991 Dec. 7(6):- Myer CM 3d. [View Abstract]
  10. Salamone FN, Bobbitt DB, Myer CM, Rutter MJ, Greinwald JH Jr. Bacterial tracheitis reexamined: is there a less severe manifestation?. Otolaryngol Head Neck Surg. 2004 Dec. 131(6):871-6. [View Abstract]
  11. Hopkins BS, Johnson KE, Ksiazek JM, et al. H1N1 influenza A presenting as bacterial tracheitis. Otolaryngol Head Neck Surg. 2010 Apr. 142(4):612-4. [View Abstract]
  12. Mandal A, Kabra SK, Lodha R. Upper Airway Obstruction in Children. Indian J Pediatr. 2015 Aug. 82 (8):737-44. [View Abstract]
  13. Fergie J, Purcell K. The treatment of community-acquired methicillin-resistant Staphylococcus aureus infections. Pediatr Infect Dis J. 2008 Jan. 27(1):67-8. [View Abstract]
  14. [Guideline] Tablan OC, Anderson LJ, Besser R, Bridges C, Hajjeh R. Guidelines for preventing health-care--associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep. 2004 Mar 26. 53:1-36. [View Abstract]
  15. Gross JH, Giraldez-Rodriguez LA, Klein AM. Bacterial Laryngotracheitis and Associated Upper Airway Obstruction: A Case Series. Ann Otol Rhinol Laryngol. 2015 Dec. 124 (12):1002-5. [View Abstract]
  16. Bernstein T, Brilli R, Jacobs B. Is bacterial tracheitis changing? A 14-month experience in a pediatric intensive care unit. Clin Infect Dis. 1998 Sep. 27(3):458-62. [View Abstract]
  17. Brook I. Aerobic and anaerobic microbiology of bacterial tracheitis in children. Pediatr Emerg Care. 1997 Feb. 13(1):16-8. [View Abstract]
  18. Cherry JD. Croup (laryngitis, laryngotracheitis, spasmodic croup, and laryngotracheobronchitis). Textbook of Pediatric Infectious Diseases. 1998. 234-238.
  19. Donnelly BW, McMillan JA, Weiner LB. Bacterial tracheitis: report of eight new cases and review. Rev Infect Dis. 1990 Sep-Oct. 12(5):729-35. [View Abstract]
  20. Eckel HE, Widemann B, Damm M, Roth B. Airway endoscopy in the diagnosis and treatment of bacterial tracheitis in children. Int J Pediatr Otorhinolaryngol. 1993 Aug. 27(2):147-57. [View Abstract]
  21. Rotta AT, Wiryawan B. Respiratory emergencies in children. Respir Care. 2003 Mar. 48(3):248-58; discussion 258-60. [View Abstract]
  22. Burton LV, Silberman M. Bacterial Tracheitis. 2018 Jan. [View Abstract]
  23. Casazza G, Graham ME, Nelson D, Chaulk D, Sandweiss D, Meier J. Pediatric Bacterial Tracheitis-A Variable Entity: Case Series with Literature Review. Otolaryngol Head Neck Surg. 2018 Oct 23. 194599818808774. [View Abstract]

Steeple sign.

Steeple sign.